allergovit

10/01/2002 - "Patients (n=16) with grass pollen allergy were subjected to AIT with Allergovit for 5 to 6 weeks. "
09/01/2001 - "Preseasonal immunotherapy (Allergovit, Germany) was performed in conventional schedule in patients with pollinosis. "
10/01/1997 - "The immunotherapy among patients with pollen allergy was performed by individuals composed Allergovit. "
10/01/1997 - "[Results of specific immunotherapy with Allergovit in patients with pollen allergy]."
01/01/1995 - "The aim of this study was to evaluate the efficacy, tolerance and immunogenity of allergenic extracts: Allergovit and Novo-Hellisen depot (produced by Allergopharma--Germany), used for sIT in pollinosis and house dust mite allergy. "

01/01/1995 - "The aim of this study was to evaluate the efficacy, tolerance and immunogenity of allergenic extracts: Allergovit and Novo-Hellisen depot (produced by Allergopharma--Germany), used for sIT in pollinosis and house dust mite allergy. "
01/01/1995 - "It was shown that the allergenic extracts Allergovit and Novo-Helisen depot are effective in treatment of pollinosis and house dust mite allergy, and are well tolerated by the patients. "

07/01/1996 - "[Results of immunotherapy with Allergovit preparation of the Allergopharma Company in patients with hypersensitivity to pollen]."
01/01/1995 - "The sIT with Allergovit decreases the sensitivity of the peripheral blood basophils, whereas the treatment with Novo-Helisen depot causes a diminution of bronchial specific and nonspecific reactivity and a negativisation of late allergic reaction."
08/01/2016 - "Thirty persons with monovalent allergy to mugwort pollen, confirmed with skin prick tests and allergen-specific immunoglobulin E, underwent a 3-year-long allergen immunotherapy with the mugwort extract (Allergovit, Allergopharma, Germany). "

10/01/2013 - "[Effect and safety analysis of Allergovit standardized mite allergen immunotherapy in patients with allergic rhinitis]."
10/01/2013 - "To evaluate the effect and safety analysis of Allergovit standardized dust mite subcutaneous immunotherapy in patients with allergic rhinitis. "
03/01/2006 - "Allergovit immunotherapy is a safe and feasible choice for allergic rhinitis. "
03/01/2006 - "Two hundred and fifty-six patients with allergic rhinitis received Allergovit immunotherapy, their local and systemic side-effect were observed, recorded and analyzed during the treatment. "
03/01/2006 - "To analyse the safety of Allergovit immunotherapy in patients of allergic rhinitis. "